LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Genetic Disease Identified in Children

By LabMedica International staff writers
Posted on 09 Apr 2014
Print article
Image: HiSeq2000 sequencing platform (Photo courtesy of Illumina).
Image: HiSeq2000 sequencing platform (Photo courtesy of Illumina).
A new genetic disease that causes neurologic, muscle, eye and liver problems in children has been identified by a combination of modern gene-sequencing techniques.

Mutations in the gene coding for N-glycanase 1 (NGLY1), an enzyme that recycles defective products from a cellular assembly line, was found in children who have varying degrees of movement disorders, including a characteristic combination of muscle contractions that causes abnormal tremulous movements.

Scientists at Lucile Packard Children’s Hospital (Palo Alto, CA, USA) and an international team of collaborators found eight children who through case reports and social media had clinical symptoms similar to an initial case and were found in a matter of months. All patients had global developmental delay, a movement disorder, and hypotonia. Other common findings included hypolacrima or alacrima (7/8), electroencephalography (EEG) abnormalities (7/8), elevated liver transaminases (6/7), microcephaly (6/8), abnormal brain imaging (6/8), diminished reflexes (6/8).

Exome sequencing was performed in the different collaborating laboratories using the HiSeq2000 platform (Illumina; San Diego, CA, USA) and the SureSelect Human All Exon 50 Mb Kit (Agilent; Santa Clara CA, USA) and for all patients, variants were confirmed by Sanger sequencing. The nonsense mutation c.1201A>T (p.R401X) was the most common deleterious allele identified, present in the homozygous state in five of eight cases and in the compound heterozygous state in one case. Two patients did not carry the c.1201A>T (p.R401X) mutation and their clinical phenotype was relatively mild by comparison.

The study confirmed that children with a defective NGLY1 gene do not make the N-glycanase enzyme. The scientists also observed that the children's liver biopsies contained an amorphous substance, which they suspected was an accumulation of protein that did not get recycled. Gregory Enns, MB, ChB, an associate professor of genetics in pediatrics and co-lead author, said, “This represents a complete change in the way we're going about clinical medicine. This is happening so quickly because of the integration of the families with the scientists, and because so many people are coming at this from so many angles.” The study was published on March 20, 2014, in the journal Genetics in Medicine.

Related Links:

Lucile Packard Children’s Hospital
Illumina
Agilent


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more